Study reveals propolis potential for metabolic disorder patients

A recent clinical study shows that HDI Propoelix propolis extract can support the immune system in patients with metabolic disorders such as diabetes, obesity, and hypertension. The 30-day study was conducted at RS Soerojo Magelang and presented at a seminar in Jakarta on March 7, 2026. Experts emphasize that the supplement serves only as a complement, not a replacement for medical therapy.

The 25th clinical study by HDI Propoelix, recently published, explores the benefits of propolis extract for adult patients with metabolic conditions. Conducted at RS Soerojo Magelang, a vertical hospital under Indonesia's Ministry of Health, it involved office workers aged 25-60, including those with obesity and diabetes.

Over 30 days, the research found that propolis supplement use maintains immune system balance without raising inflammation risk. Laboratory examinations showed acute-phase white blood cells more prepared for mild infections, while platelet and neutrophil profiles remained stable, and inflammation indicators did not increase.

At a press conference in Central Jakarta and the National Health Seminar titled 'Beyond the Fundamentals of Propolis Science: Clinical Evidence Behind HDI Propoelix' on Saturday, March 7, 2026, lead researcher Dr. H. Harli Amir Mahmudji, Sp.PD-KEMD, stated, "In chronic patients, the immune system remains balanced and inflammation risk does not increase." He emphasized, "This is a complement, not a replacement for medical therapy."

Dr. Muhamad Sahlan, S.Si., M.Eng., from Universitas Indonesia, added, "Propolis is one of the natural materials with very high complexity of bioactive compounds. The challenge is how to ensure standardization and scientific proof so it can be accepted in modern medical practice. Efforts like those by HDI are important to bridge basic science with clinical applications."

The researchers acknowledged the study's limitations, such as its short duration and limited participants, calling for further research with larger samples. Harli also highlighted the importance of balanced nutritious eating and regular exercise as primary ways to maintain immunity, with supplements serving only as adjuvants.

Labaran da ke da alaƙa

Illustration of Nitraria roborowskii desert shrub with red berries in a sandy landscape, accompanied by a vial of extract and scientific charts on insulin signaling for a news article on diabetes research in mice.
Hoton da AI ya samar

Desert berry extract linked to improved insulin signaling in diabetic mice, study reports

An Ruwaito ta hanyar AI Hoton da AI ya samar An Binciki Gaskiya

An extract from Nitraria roborowskii, a desert shrub used in traditional Chinese medicine, improved insulin sensitivity and metabolic markers in diabetic mice by reactivating the PI3K/AKT pathway, according to a peer‑reviewed study in the Chinese Journal of Modern Applied Pharmacy and a summary posted on ScienceDaily.

Researchers at University College London have discovered how the body naturally shuts down inflammation using fat-derived molecules called epoxy-oxylipins. These molecules prevent the buildup of immune cells linked to chronic diseases like arthritis and heart disease. A study involving a drug that boosts these molecules showed faster pain relief and reduced harmful immune activity.

An Ruwaito ta hanyar AI

Researchers at the University of Oklahoma have discovered that a compound produced by healthy gut bacteria can reduce the risk of fatty liver disease in the offspring of mice fed a high-fat, high-sugar diet during pregnancy and nursing. The compound, indole, derived from breaking down the amino acid tryptophan, improved liver health, blood sugar levels, and weight management in the young mice. This finding highlights the role of the maternal microbiome in preventing metabolic disorders like MASLD in children.

Researchers have discovered a unique oral microbiome signature in people with obesity, potentially offering early detection and prevention strategies. The finding, based on saliva samples from Emirati adults, highlights differences in bacteria and metabolic pathways associated with metabolic dysfunction. However, scientists caution that the relationship's causality remains unclear.

An Ruwaito ta hanyar AI An Binciki Gaskiya

Researchers report that small doses of the antibiotic cephaloridine can prompt certain gut bacteria to increase production of colanic acid, a microbial polysaccharide previously tied to longer lifespan in laboratory animals. In experiments, treated roundworms lived longer and mice showed shifts in cholesterol or insulin measures associated with aging, with the team arguing the approach works by acting in the gut rather than throughout the body.

Researchers have identified beta-sitosterol from Aloe vera as a potential inhibitor of enzymes linked to Alzheimer’s disease. Using computer simulations, the compound demonstrated strong binding to acetylcholinesterase and butyrylcholinesterase, key players in cognitive decline. The findings, published in Current Pharmaceutical Analysis, suggest a promising avenue for plant-based treatments.

An Ruwaito ta hanyar AI

Recent research shows that body fat is more than a calorie store; it actively regulates immune responses and blood pressure. Scientists have identified specialized fat depots near the intestines that coordinate immunity against gut microbes, while another study links beige fat around blood vessels to vascular health. These findings challenge simplistic views of fat as merely harmful.

 

 

 

Wannan shafin yana amfani da cookies

Muna amfani da cookies don nazari don inganta shafin mu. Karanta manufar sirri mu don ƙarin bayani.
Ƙi